A single institutional outcome analysis of Gamma Knife radiosurgery for single or multiple brain metastases☆
Introduction
Over the past several decades, whole brain radiation therapy has emerged as the standard treatment of choice for single or multiple brain metastases. However, for the solitary brain metastasis, surgery plus whole brain radiation has been proven to deliver superior local control and survival rates as compared with whole brain radiation alone [1], [2]. More recently, stereotactic radiosurgery (SRS) has been established as a potentially superior alternative to surgical resection by virtue of its lower morbidity [3], [4], [5]. Although SRS is being used with increasing frequency for the treatment of brain metastases, optimal patient selection and treatment factors continue to be investigated. The aim of this study was to provide outcome data from a single institutional, retrospective experience with Gamma Knife SRS and to identify prognostic factors for the proper selection and treatment of patients.
Section snippets
Materials and methods
From July 1990 to April 1997, 54 patients with solitary or multiple brain metastases were treated using Gamma Knife SRS. Of the 54, we analyzed 51 patients whose treatment results were evaluated properly with CT and/or MRI. Follow-up period ranged 1.5–84.4 months with a median of 23.4 months. There were 28 males and 23 females, with a median age of 60 years (range: 33–88, mean 59.4 years). Karnofsky Index (KI) was 50 in one, 60 in five, 70 in 14, 80 in 12, 90 in 18, and 100 in one patient with
Results
Initial local response and its relationship to local control rate are shown in Table 4. Local control was achieved in 47 tumors (69%). In the patients with local recurrence, time to the recurrence ranged from 1 to 20 months with an average of 4.6 and median of 3 months. The actuarial 1-year, 2-year, 3-year, and 5-year survival rates were 44.2, 22.0, 21.0, and 15.8%. The median survival period were 7.4 months. The actuarial 1-year, 3-year, and 5-year local control rates were 62.3, 51.9, 51.9,
Discussion
Combined surgical resection and whole brain radiotherapy have been a mainstay of the treatment of cerebral metastases. This approach results in a median survival of approximately 10 months [1], [2]. Recent publications have suggested that similar results can be achieved with SRS for the solitary brain metastasis [3], [4], [5]. The overall conclusion of previous publications appears to be that the median survival for the patients with cerebral metastases ranges 7–10 months regardless of
Acknowledgements
This work was supported in part by a grant from the Ministry of Education of Japan.
References (11)
- et al.
The choice of treatment of single brain metastasis should be made based on extra-cranial tumor activity and age
Int. J. Radiat. Oncol. Biol. Phys.
(1994) - et al.
Identification of an optimal subgroup for treatment evaluation of patients with brain metastases using RTOG Study 6916
Int. J. Radiat. Oncol. Biol. Phys.
(1989) - et al.
A randomized trial of surgery in the treatment of single metastases to the brain
N. Engl. J. Med.
(1990) - et al.
A multi-institutional outcome and prognostic analysis of radiosurgery for resectable single brain metastasis
Int. J. Radiat. Oncol. Biol. Phys.
(1996) - et al.
Long-term follow-up of patients treated with stereotactic radiosurgery for single or multiple brain metastases
Radiosurgery
(1995)
Cited by (28)
Delayed complications in patients surviving at least 3 years after stereotactic radiosurgery for brain metastases
2013, International Journal of Radiation Oncology Biology PhysicsCitation Excerpt :In our present study, the only factor associated with delayed complications was larger tumor volume. Nakagawa et al reported prior or concomitant WBRT to be a possible risk factor for low-grade dementia (16). We also observed 1 patient in whom severe dementia occurred after WBTR followed by GKRS (8).
Early detection of metachronous brain metastases by biannual brain MRI follow-up may provide patients with non-small cell lung cancer with more opportunities to have radiosurgery
2010, Clinical Neurology and NeurosurgeryCitation Excerpt :In contrast, several trials of PCI in NSCLC have shown a decrease in development of brain metastases but not a survival advantage [1–3,8,9]. In addition, whole brain radiation therapy (WBRT) has the potential risk of neurocognitive complications [10–13]. These studies raise the issue whether all patients with NSCLC should receive PCI [6].
Clinical outcome of hypofractionated conventional conformation radiotherapy for patients with single and no more than three metastatic brain tumors, with noninvasive fixation of the skull without whole brain irradiation
2006, International Journal of Radiation Oncology Biology PhysicsSurgical and radiosurgical management of brain metastases
2005, Surgical Clinics of North AmericaCitation Excerpt :Median time between diagnosis of primary lesion and metastasis is approximately 2 years [83]. Surgery and radiosurgery are options [83,84]. Metastases from unknown primary tumors, despite adequate systemic imaging evaluations, usually are diagnosed surgically [85].
Palliative radiation therapy
2005, Seminars in Oncology
- ☆
This work was done at the University of Tokyo Hospital.